After closing Spain’s largest biopharma Series A round, the company SpliceBio has set its foundations in the gene therapy field and joins the push to deliver bigger therapeutic genes into patients.
eureKARE participates in DNA Script's $200 Million Series C Financing Fundraise will accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris
/PRNewswire/ Coave Therapeutics ( Coave ), a clinical-stage biotechnology company focused on developing life-changing gene therapies in rare Ocular and CNS.
/PRNewswire/ Coave Therapeutics ( Coave ), a clinical-stage biotechnology company focused on developing life-changing gene therapies in rare Ocular and CNS.